Clinical Trial Update: Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nivolumab alone or with vinblastine in classical Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• nivolumab (nivolumab)
• vinblastin (vinblastine)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Hodgkin Lymphoma, Coexisting Medical Conditions | Phase 2 | Status: COMPLETED